VAERS reports by lot

Novavax COVID-19 lot 4302MF023: VAERS reports

150 VAERS reports list lot 4302MF023 as a Novavax COVID-19 vaccine, received between 2022-07-28 and 2024-09-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
150
Reports
7%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological12121%
General / Systemic (non-local)12021%
Cardiac / Cardiovascular7914%
Gastrointestinal519%
Injection-site / Local reaction488%
Musculoskeletal448%
Respiratory376%
Dermatological (non-injection-site)275%
Psychiatric / Neuropsychiatric183%
Allergic / Anaphylactic153%
Thrombotic / Hematological92%
Autoimmune / Immune-mediated71%
Reproductive / Menstrual51%

Where reports came from

U.S. state of the reporter, where given (top 12).

California30
Texas9
New York9
Florida7
New Jersey6
Washington6
Colorado6
Virginia4
Nevada4
Georgia4
Wisconsin4
Tennessee3

Reports by month received

2022-073
2022-0838
2022-0925
2022-1017
2022-1115
2022-1217
2023-015
2023-0212
2023-036
2023-043
2023-051
2023-061
2023-091
2023-102
2023-111
2024-021
2024-061
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.